MedPath

PT. Prodia Stem Cell Indonesia

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

11

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:9
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials

Phase 1
9 (90.0%)
Phase 2
1 (10.0%)

Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II

Phase 2
Not yet recruiting
Conditions
Retinitis Pigmentosa
Interventions
Biological: 1.5 x 10^6 UC-MSC + CM
Biological: 5 x 10^6 UC-MSC + CM
First Posted Date
2023-06-18
Last Posted Date
2025-07-10
Lead Sponsor
PT. Prodia Stem Cell Indonesia
Target Recruit Count
30
Registration Number
NCT05909488
Locations
🇮🇩

RSUP Dr. Sardjito, Yogyakarta, DI Yogyakarta, Indonesia

Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa

Conditions
Retinitis Pigmentosa
First Posted Date
2023-03-27
Last Posted Date
2023-06-13
Lead Sponsor
PT. Prodia Stem Cell Indonesia
Target Recruit Count
18
Registration Number
NCT05786287
Locations
🇮🇩

Jakarta Eye Center Hospital, Jakarta, DKI Jakarta, Indonesia

🇮🇩

Sardjito Hospital, Yogyakarta, Special Region, Indonesia

Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.

Phase 1
Recruiting
Conditions
Polycystic Ovary Syndrome
First Posted Date
2022-03-15
Last Posted Date
2022-09-26
Lead Sponsor
PT. Prodia Stem Cell Indonesia
Target Recruit Count
40
Registration Number
NCT05279768
Locations
🇮🇩

PT Prodia StemCell Indonesia, Jakarta, Indonesia

Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer

Phase 1
Recruiting
Conditions
Nasopharyngeal Cancer
First Posted Date
2022-03-02
Last Posted Date
2022-09-26
Lead Sponsor
PT. Prodia Stem Cell Indonesia
Target Recruit Count
15
Registration Number
NCT05261750
Locations
🇮🇩

PT Prodia StemCell Indonesia, Jakarta, Indonesia

Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct

Phase 1
Recruiting
Conditions
Ischemic Stroke
First Posted Date
2021-08-17
Last Posted Date
2022-09-26
Lead Sponsor
PT. Prodia Stem Cell Indonesia
Target Recruit Count
15
Registration Number
NCT05008588
Locations
🇮🇩

Gatot Soebroto Hospital, Jakarta Pusat, DKI Jakarta, Indonesia

🇮🇩

PT Prodia StemCell Indonesia, Jakarta, Indonesia

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.